CAS No. |
2553413-86-6 |
|---|---|
中文名称 |
7-((2R,5R,7R,8R,10R,12aR,14R,15R,15aR,16R)-14-(6-氨基-9H-嘌呤-9-基)-15-氟-16-羟基-2,10-二巯基-2,10-二氧代-八氢-12H-5,8-亚甲基-呋喃并[3,2-l][1,3,6,9,11]五氧杂[2,10]二磷杂环十四烯-7-基)-5-氟-1,7-二氢-4H-吡咯并[2,3-d]嘧啶-4-酮 |
英文名称 |
7-((2R,5R,7R,8R,10R,12aR,14R,15R,15aR,16R)-14-(6-Amino-9H-purin-9-yl)-15-fluoro-16-hydroxy-2,10-dimercapto-2,10-dioxidooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecin-7-yl)-5-fluoro-1,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one |
别名 |
7-Deazainosine, [P(R)]-2'-deoxy-2'-fluoro-5'-O-[(R)-hydroxymercaptophosphinyl]-P-thioadenylyl-(3'→5')-7-fluoro-, cyclic (2'→5')-nucleotide;Dazostinag |
标准英文名 |
7-((2R,5R,7R,8R,10R,12aR,14R,15R,15aR,16R)-14-(6-amino-9H-purin-9-yl)-15-fluoro-16-hydroxy-2,10-dimercapto-2,10-dioxidooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecin-7-yl)-5-fluoro-1,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one |
分子式 |
C21H22F2N8O10P2S2 |
分子量 |
710.53 |
精确分子量 |
710.03 |
SMILES |
NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@@](=O)(S)O[C@@H]5[C@H](O)[C@@H](CO[P@@](=O)(S)O[C@H]4[C@H]3F)O[C@H]5N3C=C(F)C4=C3NC=NC4=O)C2=NC=N1 |
标准SMILES |
NC1N=CN=C2C=1N=CN2[C@@H]1O[C@@H]2CO[P@@](=O)(S)O[C@@H]3[C@H](O)[C@@H](CO[P@@](=O)(S)O[C@H]2[C@H]1F)O[C@H]3N1C=C(F)C2=C1NC=NC2=O |
用途 |
Dazostinag (TAK-676 freebase) is an agonist of the stimulator of interferon genes (STING) protein with antitumor activity; it can be used as a payload for the synthesis of antibody-drug conjugates (ADCs). |
InChIKey |
SIIGKCBSQKWSLM-RNPBXGGWSA-N |
|
|
评论 |
|---|